Easter Campaign 2021 – THANK YOU
A HEARTFELT THANK YOU!
We are overwhelmed by the response we have received to the Easter appeal for donations. Over 20,000 euros have been received on our donation account so far.
This wonderful response from so many people helps us to continue to do everything we can to ensure…
Moose + Reindeer bring donation
On 6 December 2020, mulled wine, hot cider and organic juice, as well as lard bread and goose fat, were served at the Nidda-Kampfbahn restaurant for a good cause. The demand was so great that Mary Massieu, accompanied by a moose and reindeer, was able to bring us a proud 600 eur…
Donation from Meseth GmbH
We were delighted to welcome Nicole Pilsel and Marina Schloßnagel from the Frankfurt roofing company Hans Jürgen Meseth GmbH to our research house on 9 December 2020. Not only did they show great interest in the important research work at the Dr. Petra Joh-Haus, but they also ha…
WCP thinks of fellow men
For the third time, our board member Rudolf Starck was able to receive a generous donation from Sven Mattis, owner of the company WCP, on 20 November 2020. With 10,000 euros, WCP GmbH is once again supporting the research and work of the Frankfurt Foundation for Children with Ca…
Award of the Maresch-Klingelhöffer Prize
Prof. Jindrich Cinatl, Dr. Constanze Schneider, Dr. Jürgen Vogt
As part of the ceremony to mark the 25th anniversary of the Frankfurt Foundation for Children with Cancer in November 2019, Dr. Constanze Schneider was awarded the Maresch-Klingelhöffer Prize.
The prize has been awa…
Season farewell Niddastrand
The “Niddastrand” in Frankfurt-Nied ended this year’s season with an event on 4 October 2020.
The head of the town Susanne Serke and her husband, the two Eintracht legends Kumljenovic and Skela, Frank Rusko from the Stadtmission Frankfurt-Nied and the restaurant Niddakampfbahn p…
OMV Freigericht 2020
The fourth charity star ride of the OMV Freigericht at Whitsun fell victim to the corona virus. Nevertheless, we received a donation for which we would like to express our sincere thanks.
40 participants were already registered, 34 had already paid their entry fee. 2,730 Euros w…
New insights into ALL therapy
Mystery of anticancer drug nelarabine for leukaemia treatment solved
Acute lymphoblastic leukaemia (ALL) is the most common cancer in children. With the active substance nelarabine, T-ALL, a subtype that resembles T-lymphocytes, can be treated well. However, B-ALL, a subtype tha…
